News

AMN Healthcare (NYSE: AMN) is one of 380 companies across 11 industry sectors and 44 countries included in the 2021 Bloomberg Gender-Equality Index (GEI). In the healthcare sector, AMN Healthcare

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with Cypre, Inc., a biotechnology company that is using 3D hydrogel

Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.19 per share of Class A common stock issued and

Premier Inc. (NASDAQ: PINC), through its ProvideGx® program, has partnered with Pfizer Inc. to supply five essential medications to healthcare providers, helping to meet the immediate and long-term

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2020 financial results and provide 2021 guidance on Wednesday, February 17^th, before the market

AMN Healthcare’s commitment to developing comprehensive and integrated solutions to the challenges faced by healthcare organizations has resulted in a top-ten ranking among leaders in total

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, has scheduled a conference call to discuss its fourth quarter and full

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a strategic partnership with JADE Biomedical (JADE), a provider of end-to-end quality management

In connection with the Company’s participation at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, AMN Healthcare Services Inc. (NYSE: AMN) is providing preliminary unaudited

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at the 39^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12^th, at 10:00

Novocure (NASDAQ: NVCR) today reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2020. Novocure plans to discuss these

Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 second quarter on Tuesday, February 2, 2021, at approximately 6:30 a.m. ET. The company will

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, and The University of Texas

Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a presentation and fireside chat at the 39

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination of an exclusive

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) (“Acadia” or the “Company”) today announced that it has entered into a definitive agreement to sell its U.K. operations to Waterland Private Equity

Novocure (NASDAQ: NVCR) will participate virtually in the 39^th Annual J.P. Morgan Healthcare Conference on January 11 through January 14, 2021. William Doyle, Novocure’s Executive Chairman, will

Health Resource Services (HRS), a national, provider-owned group purchasing organization (GPO) founded by Virginia Mason Health System, today announced that they will partner with Premier Inc.

For its dedication to addressing social issues and supporting people and communities locally, nationally and globally, AMN Healthcare (NYSE: AMN) has been named one of the country’s most

Novocure (NASDAQ:NVCR) gab heute bekannt, dass das Schweizerische Bundesamt für Gesundheit (BAG) Optune in Kombination mit Temozolomid mit Wirkung vom 1. April 2021 in die Mittel- und

Novocure (NASDAQ:NVCR) announced today that the Swiss Federal Office of Public Health (BAG) has added Optune in combination with temozolomide to the List of Remedies and Equipment (MiGeL) for the

Novocure (NASDAQ: NVCR) today announced the first patient has been enrolled in its global phase 3 TRIDENT trial, a randomized study in newly diagnosed glioblastoma (GBM) testing the potential

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it has formed a joint venture with Henry Ford Health System, one of Michigan’s premier, academic and integrated health systems

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is the first company to offer clients Good Laboratory Practices (GLP) validated digital peer review using Deciphex

Premier Inc. (NASDAQ: PINC) has named St. Luke’s University Health Network, a fully integrated, nationally recognized health network serving Pennsylvania and New Jersey, the winner of the 2020